These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3830796)

  • 1. [Analysis of the concentration of VP 16 and VM 26 in human brain neoplasms].
    Zucchetti M; Rossi C; Gaetani P; Silvani V; Knerich R; Butti G; Donelli MG; D'Incalci M
    G Ital Chemioter; 1985; 32(1):83-6. PubMed ID: 3830796
    [No Abstract]   [Full Text] [Related]  

  • 2. Etoposide and teniposide. Bioanalysis, metabolism and clinical pharmacokinetics.
    Holthuis JJ
    Pharm Weekbl Sci; 1988 Jun; 10(3):101-16. PubMed ID: 3047665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay for etoposide and teniposide.
    Ho DH; Kanellopoulos KS; Brown NS; Issell BF; Bodey GP
    J Immunol Methods; 1985 Dec; 85(1):5-15. PubMed ID: 4078312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated liquid chromatographic analysis of the anti-tumorigenic drugs etoposide (VP 16-213) and teniposide (VM 26).
    Werkhoven-Goewie CE; Brinkman UA; Frei RW; de Ruiter C; de Vries J
    J Chromatogr; 1983 Sep; 276(2):349-57. PubMed ID: 6630384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic analysis of the semisynthetic epipodophyllotoxins teniposide and etoposide using electrochemical detection.
    Sinkule JA; Evans WE
    J Pharm Sci; 1984 Feb; 73(2):164-8. PubMed ID: 6707876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 1-beta-D-arabinofuranosylcytosine transport and net accumulation by teniposide and etoposide in Ehrlich ascites cells and human leukemic blasts.
    White JC; Hines LH; Rathmell JP
    Cancer Res; 1985 Jul; 45(7):3070-5. PubMed ID: 4005845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podophyllotoxin derivatives VP-16 and VM-26.
    D'Incalci M; Garattini S
    Cancer Chemother Biol Response Modif; 1988; 10():57-63. PubMed ID: 3079398
    [No Abstract]   [Full Text] [Related]  

  • 8. Podophyllotoxin derivatives VP-16 and VM-26.
    D'Incalci M; Garattini S
    Cancer Chemother Biol Response Modif; 1987; 9():67-70. PubMed ID: 3079416
    [No Abstract]   [Full Text] [Related]  

  • 9. 4'-Demethylepipodophyllotoxin-beta-D-glucoside: a new podophyllotoxin derivative with VM-26-like and VP-16-213-like activities.
    Gupta RS; Singh B
    J Natl Cancer Inst; 1984 Jul; 73(1):241-8. PubMed ID: 6588229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teniposide (VM-26)- and etoposide (VP-16-213)-induced augmentation of methotrexate transport and polyglutamylation in Ehrlich ascites tumor cells in vitro.
    Yalowich JC; Fry DW; Goldman ID
    Cancer Res; 1982 Sep; 42(9):3648-53. PubMed ID: 6179605
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion.
    Montaldo PG; Figoli F; Zanette ML; Sorio R; Zucchetti M; Tirelli U; D'Incalci M
    Oncology; 1990; 47(1):55-61. PubMed ID: 2300386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detection.
    Strife RJ; Jardine I; Colvin M
    J Chromatogr; 1981 Jun; 224(1):168-74. PubMed ID: 7263816
    [No Abstract]   [Full Text] [Related]  

  • 13. Pediatric cancer chemotherapy: an updated review. I. Cis-Diammine--dichloroplatinum II (cisplatin), VM-26 (teniposide), VP-16 (etoposide), mitomycin C.
    Gutierrez ML; Crooke ST
    Cancer Treat Rev; 1979 Sep; 6(3):153-64. PubMed ID: 394834
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mutagenicity tests of etoposide and teniposide].
    Nakanomyo H; Hiraoka M; Shiraya M
    J Toxicol Sci; 1986 Apr; 11 Suppl 1():301-10. PubMed ID: 3761399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VM 26 and VP 16-213: a comparative analysis.
    Rozencweig M; Von Hoff DD; Henney JE; Muggia FM
    Cancer; 1977 Jul; 40(1):334-42. PubMed ID: 328129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonresponsiveness of brain tumors to VM-26 therapy in children.
    Sullivan MP; van Eys J; Herson J; Starling KA; Ragab A; Sexhauer C
    Cancer Treat Rep; 1979 Jan; 63(1):155-6. PubMed ID: 369689
    [No Abstract]   [Full Text] [Related]  

  • 17. Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26).
    Haim N; Roman J; Nemec J; Sinha BK
    Biochem Biophys Res Commun; 1986 Feb; 135(1):215-20. PubMed ID: 3006680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precipitation of teniposide during infusion.
    Am J Hosp Pharm; 1990 Mar; 47(3):512, 518. PubMed ID: 2316530
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison between VP 16 and VM 26 in Lewis lung carcinoma of the mouse.
    Colombo T; Broggini M; Vaghi M; Amato G; Erba E; D'Incalci M
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):173-9. PubMed ID: 3699080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-beta-D-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) and their metabolites on human leukemic lymphoblasts.
    Dow LW; Sinkule JA; Look AT; Horvath A; Evans WE
    Cancer Res; 1983 Dec; 43(12 Pt 1):5699-706. PubMed ID: 6580063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.